Research
Read how they describe their research on their Université de Montréal profile.
Latest papers
MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.
Blood advances · 2026 · senior author
Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.
Case reports in hematology · 2026 · senior author
Confronting high-complexity situations in myeloproliferative neoplasms: from treating young patients to TP53-mutated and 'unclassifiable' entities.
Current opinion in hematology · 2026 · first author
Latest funding
- $1,350,226
Low-dose direct oral anticoagulant compared to aspirin for the thromboprophylaxis of patients with JAK2-positive myeloproliferative neoplasms
CIHR · 2024 · Co-investigator
- $103,728
Chercheurs-boursiers cliniciens
FRQS · 2021 · Principal investigator
- $45,000
Établissement de jeunes chercheurs cliniciens
FRQS · 2021 · Principal investigator
25 publications.
MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.
Ouellet M, Rizzolo A, Venne C, Moussa H, Bilodeau K, Mollica L, Chabot-Roy G, Huynh-Trudeau G, Lesage S, Harnois M, Busque L, Sirhan S, Szuber N
Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.
Larin É, Busque L, Chabot-Roy G, Lesage S, Jadot G, LeBlanc R, Roy J, Claveau JS, Szuber N
Confronting high-complexity situations in myeloproliferative neoplasms: from treating young patients to TP53-mutated and 'unclassifiable' entities.
Szuber N
Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group.
Poullet A, Busque L, Sirhan S, Delage R, Cournoyer G, Chamakhi I, Talbot D, Mollica L, Marceau D, Ethier V, Desjardins P, Olney HJ, Harnois M, Szuber N
Essential Thrombocythemia: A Review.
Tefferi A, Gangat N, Loscocco GG, Guglielmelli P, Szuber N, Pardanani A, Orazi A, Barbui T, Vannucchi AM
Asciminib versus bosutinib following 2 or more prior therapies in chronic myeloid leukemia: a plain language summary of the ASCEMBL study.
Szuber N, Machado L, Kim DDH
JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management.
Gangat N, Szuber N, Tefferi A
Triple A Plus (AAA +) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients.
Tefferi A, Loscocco GG, Rokach L, Tadmor T, Faldu P, Melamed G, Alapi H, Abdelmagid M, Abdelaziz RM, Yousuf M, Nakhleh M, Pardanani A, Begna KH, Patnaik MM, Szuber N, Carobbio A, Barbui T, Reichard KK, He R, Guglielmelli P, Gangat N, Vannucchi AM
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study
England JT, Szuber N, Sirhan S, Dunne T, Cerquozzi S, Hill M, Villeneuve PJA, Ho JM, Sadikovic B, Bhai P
CALR mutation burden in essential thrombocythemia and disease outcome.
Guglielmelli P, Szuber N, Gangat N, Capecchi G, Maccari C, Harnois M, Karrar O, Abdelmagid M, Balliu M, Nacca E, Atanasio A, Sestini I, Désilets A, Loscocco GG, Rotunno G, Busque L, Tefferi A, Vannucchi AM
Low-dose direct oral anticoagulant compared to aspirin for the thromboprophylaxis of patients with JAK2-positive myeloproliferative neoplasms
Principal investigators: Kimpton, Miriam; Delluc, Aurelien
Keywords: Cancer; Cardiovascular Outcomes; Randomized Controlled Trial; Thrombosis
Chercheurs-boursiers cliniciens
Principal investigators: Szuber, Natasha
Keywords: ERYTHROCYTOSIS, POLYCYTHEMIA VERA, EPIDEMIOLOGY, CLINICAL OUTCOMES, PROGNOSTIC FACTORS, GENOMIC SIGNATURES; Cancer; Hématologie; Épidémiologie
Établissement de jeunes chercheurs cliniciens
Principal investigators: Szuber, Natasha
Keywords: Non disponible
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
- Vikas Gupta and Dawn Maze: 21 shared papers
- Hassan Sibai and Dawn Maze: 19 shared papers
- Hassan Sibai and Vikas Gupta: 18 shared papers
- Christopher Hillis and Brian Leber: 15 shared papers
- Aniket Bankar and Hassan Sibai: 7 shared papers
- Aniket Bankar and Vikas Gupta: 7 shared papers
- Aniket Bankar and Dawn Maze: 7 shared papers
- Christopher Hillis and Dawn Maze: 6 shared papers
- Brian Leber and Dawn Maze: 6 shared papers
- Brian Leber and Vikas Gupta: 5 shared papers
- Christopher Hillis and Vikas Gupta: 3 shared papers
- Christopher Hillis and Bekim Sadikovic: 2 shared papers
- Christopher Hillis and Natasha Szuber: 2 shared papers
- Brian Leber and Bekim Sadikovic: 2 shared papers
- Marie-Pierre Dubé and Natasha Szuber: 2 shared papers
- Jean Roy and Sylvie Lesage: 2 shared papers
- Sylvie Lesage and Natasha Szuber: 2 shared papers
- Vikas Gupta and Natasha Szuber: 2 shared papers
- Dawn Maze and Natasha Szuber: 2 shared papers
- Brian Leber and Jean Roy: 1 shared paper
- Brian Leber and Natasha Szuber: 1 shared paper
- Jean Roy and Natasha Szuber: 1 shared paper
- Marie Trudel and Natasha Szuber: 1 shared paper
- Sylvie Lesage and Karine Bilodeau: 1 shared paper
- Karine Bilodeau and Natasha Szuber: 1 shared paper
- Bekim Sadikovic and Aniket Bankar: 1 shared paper
- Bekim Sadikovic and Natasha Szuber: 1 shared paper
- Aniket Bankar and Natasha Szuber: 1 shared paper
- Hassan Sibai and Natasha Szuber: 1 shared paper
- Inès Chamakhi and Natasha Szuber: 1 shared paper
- Harold Olney and Natasha Szuber: 1 shared paper
- Department of Medicine
- Department of Oncology
- Department of Microbiology, Infectious Diseases and Immunology
- Department of Pathology and Laboratory Medicine
- Department of Philosophy
- Other
Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Lambert Busque
Department of Medicine
10 shared papers, latest 2026
Sylvie Lesage
Department of Microbiology, Infectious Diseases and Immunology
2 shared papers, latest 2026
Marie-Pierre Dubé
Department of Medicine
2 shared papers, latest 2023
Vikas Gupta
Department of Medicine
2 shared papers, latest 2024
Dawn Maze
Department of Medicine
2 shared papers, latest 2024
Christopher Hillis
Department of Oncology
2 shared papers, latest 2024
Bekim Sadikovic
Department of Pathology and Laboratory Medicine
1 shared papers, latest 2024
Aniket Bankar
Department of Medicine
1 shared papers, latest 2024
Hassan Sibai
Department of Medicine
1 shared papers, latest 2024
Inès Chamakhi
Department of Medicine
1 shared papers, latest 2025
Harold Olney
Department of Medicine
1 shared papers, latest 2021
Brian Leber
Department of Medicine
1 shared papers, latest 2022
Premysl Ponka
Department of Physiology
1 shared papers, latest 2008
Jean Roy
Department of Philosophy
1 shared papers, latest 2026
Marie Trudel
Department of Medicine
1 shared papers, latest 2008
Karine Bilodeau
Faculty
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.